# Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

> **NCT00563446** · NA · COMPLETED · sponsor: **Hospital Authority, Hong Kong** · enrollment: 16 (estimated)

## Conditions studied

- Anemia
- Kidney Failure, Chronic
- Peritoneal Dialysis, Continuous Ambulatory

## Interventions

- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00563446
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2011-06-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563446, "Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00563446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*